DCGO · DocGo Inc. · Financials
The latest filing states the doubt was alleviated.
“While these plans carry meaningful inherent risk to operations and involve a significant number of steps and components, the Company's management and the Board of Directors have evaluated these conditions in totality and believe it is probable that, when implemented, the plans will be sufficient to alleviate substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance date.”View the 10-Q filed Aug 17, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|---|
| $305M – $310M | $294.72M | $322.2M | $616.56MG | $624.29M | $440.52M | $318.72M | $94.09M | |
| — | $506.22K | — | — | $1.68M | $762.69K | -$763.03K | -$204.63K | |
| — | — | — | — | — | $2.99M | $2.74M | $2.12M | |
| — | — | — | — | — | $523.95M | $451.7M | — | |
| — | — | — | — | — | -$83.43M | -$132.98M | — | |
| — | — | — | — | — | -18.94% | -41.72% | — | |
| — | $14.12M | $13.56M | $11.59M | $10.86M | $5.38M | $3.32M | $1.19M | |
| — | $1.52M | $1.42M | $1.51M | $2.8M | $4.76M | $4.76M | $746.24K | |
| — | $129.88M | $133.45M | $138.76M | $137.15M | $103.4M | $74.89M | $34.91M | |
| — | $2.91M | $5.58M | $5.66M | $5.25M | $3.21M | $1.85M | $1.45M | |
| — | $13.26M | $15.66M | $15.88M | $16.43M | $10.57M | $2.31M | $5.51M | |
| — | $477.91M | $500.23M | $587.87M | $609.23M | $418.68M | $303.36M | $108.85M | |
| — | $293.76M | $315.2M | $445.21M | $475.07M | $326.09M | — | — | |
| — | -$183.19M | -$178.03M | $28.69M | $15.05M | $21.83M | $15.36M | -$14.76M | |
| — | — | -55.26% | 4.65% | 2.41% | 4.96% | 4.82% | -15.68% | |
| — | -$169.93M | -$162.37M | $44.57M | $31.49M | $32.4M | $17.67M | -$9.25M | |
| — | -$6.21M | -$9.47M | -$939.72K | $1.24M | $950.26K | -$40.09K | $300K | |
| — | -$473.25K | -$552.76K | -$316.04K | -$343.34K | $8919 | -$66.82K | — | |
| — | -$189.4M | -$187.5M | $27.75M | $16.29M | $22.78M | $19.8M | -$14.63M | |
| — | $17.29M | $8.87M | $14.39M | $6.24M | -$7.96M | $615.7K | $167.44K | |
| — | -$192.42M | -$182.4M | $19.99M | $6.86M | $34.58M | $23.74M | -$14.8M | |
| — | — | -56.61% | 3.24% | 1.1% | 7.85% | 7.45% | -15.73% | |
| — | -$14.27M | -$13.97M | -$6.63M | $3.19M | -$3.84M | -$4.56M | -$439.27K | |
| — | — | -$182.4M | $19.99M | $6.86M | $34.58M | $23.74M | -$14.36M | |
| — | -$192.97M | -$181.23M | $19.73M | $7.6M | $35.36M | $23.76M | -$14.16M | |
| USD/shares | — | -$1.95 | -$1.84 | $0.20 | $0.07 | $0.34 | $0.30 | -$0.25 |
| USD/shares | — | -$1.95 | -$1.84 | $0.18 | $0.06 | $0.34 | $0.25 | -$0.25 |
| shares | — | — | 99.07M | 102.4M | 103.51M | 101.23M | 80.29M | 58.37M |
| shares | — | — | 99.07M | 109.42M | 105.62M | 102.98M | 94.86M | 58.37M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: $28.32M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 15 similar-size Medical Care Facilities companies (of 56 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Transportation Services Segment | $200,765,608 | $193,429,092 | $181,495,105 | $114,624,306 | $84,268,817 |
| Mobile Health Services Segment | $121,430,392 | $423,126,040 | $442,793,537 | $325,891,440 | $234,449,763 |
| Corporate | $0 | $0 | $0 | $0 | $0 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| United States | $268,253,832 | $558,790,845 | $571,887,943 | $419,578,082 | $309,218,594 |
| United Kingdom | $53,942,168 | $57,764,287 | $52,400,699 | $20,937,664 | $9,499,986 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Transportation Services Segment | -$42,328,533 | -$2,045,181 | $3,541,377 | -$14,546,171 | -$20,983,766 |
| Mobile Health Services Segment | -$54,353,222 | $94,025,850 | $80,362,820 | $92,710,163 | $59,605,712 |
| Corporate | -$81,351,745 | -$63,291,943 | -$68,849,217 | -$56,332,364 | -$23,264,648 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Transportation Services Segment | -21.1% | -1.1% | 2% | -12.7% | -24.9% |
| Mobile Health Services Segment | -44.8% | 22.2% | 18.1% | 28.4% | 25.4% |